VECTURA
Live / Allowed — Published for opposition (as of 24 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 10 Oct 2023 filing date already counts against anyone who files later.
Record
- Serial number
- 98217245
- Mark type
- Stylized text
- Filed
- 10 Oct 2023
- Published for opposition
- 24 Mar 2026
- Attorney of record
- Molly B. Markley
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and veterinary preparations for the treatment of diseases or conditions of the respiratory system; pharmaceutical and veterinary preparations for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynaecological conditions; pharmaceutical and veterinary preparations for the alleviation or prevention of pain or inflammation; inhalers filled with powders for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynaecological conditions; pharmaceutical preparations, namely, powders for asthma inhalers; pharmaceutical preparations, namely, powders for transdermal injection for the alleviation or prevention of pain, for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynecological conditions; pharmaceutical and veterinary preparations for oral ingestion for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynecological conditions; pharmaceutical and veterinary preparations for topical administration for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynecological conditions; medicaments for inhalation therapy; pharmaceutical preparations, namely, pulmonary delivery compositions for use in facilitating the inhalation of pharmaceuticals, namely, drug delivery agents consisting of compounds that facilitate delivery by inhalation of a wide range of pharmaceuticals; medicaments for the treatment of erectile dysfunction; medicaments for the treatment of chronic obstructive pulmonary disease; medicaments for the treatment of premature ejaculation; medicaments for the treatment of cystic fibrosis; medicaments for the treatment of female sexual dysfunction; medicaments for the treatment of migraines; medicaments for the treatment of asthma; all of the above goods not for use in the dental field
- Class 010 — Medical apparatus: Surgical, medical, and veterinary apparatus, instruments and parts and fittings therefor, namely, drug delivery devices and parts and fittings therefor, namely, drug delivery systems being nebulizers for medical purposes; inhalers sold empty for medical or therapeutic purposes and parts and fittings therefor; active dry powder inhalers sold empty for medical or therapeutic purposes and parts and fittings therefor; passive dry powder inhalers sold empty for medical or therapeutic purposes and parts and fittings therefor; nebulisers for inhalation therapy, namely, respiration therapy, and parts and fittings therefor; inhaler devices sold empty for medical or therapeutic purposes and parts and fittings therefor; all of the above goods not for use in the dental field
- Class 040 — Treatment of materials: Custom manufacture of pharmaceuticals; Consulting services in the field of pharmaceutical formulation, development of medical applications for drugs and pharmaceutical formulations, drug design, drug formulation, pharmaceutical formulation, and development of pharmaceutical formulations
- Class 042 — Scientific and technological services: Scientific research and technological services, namely, research, design, analysis, and testing, in the field of pharmaceuticals and drug delivery systems, and drug delivery systems and devices; Scientific research and technological services, namely, research in the field of medicine; industrial analysis and research services in the fields of drug delivery systems and devices; research services in the fields of medicine; pharmaceutical research services; pharmaceutical products development services; device and product safety testing services;
Owner
- Vectura Limited, Wiltshire, GB
- Vectura Limited, Wiltshire, GB
Prior registrations
Prosecution history
- 24 Mar 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 24 Mar 2026 — PUBLISHED FOR OPPOSITION
- 18 Mar 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 27 Feb 2026 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 23 Feb 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 19 Feb 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 19 Feb 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 19 Feb 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 22 Jan 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 22 Jan 2026 — NON-FINAL ACTION E-MAILED
- 22 Jan 2026 — NON-FINAL ACTION WRITTEN
- 22 Jan 2026 — PREVIOUS ALLOWANCE COUNT WITHDRAWN
- 16 Jan 2026 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 08 Jan 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 08 Jan 2026 — ATTORNEY REVIEW COMPLETED